M. Fountoulakis

Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer’s disease and Down Syndrome

S. H. Kim, M. Fountoulakis, Nigel J. Cairns et al. · 2001 · 144 citations

Two-dimensional map of human brain proteins

Hanno Langen, Peter Berndt, Daniel Röder et al. · Electrophoresis · 1999 · 143 citations

Neurophysiological Biomarkers, Brain Mapping, Neurochemical Biomarkers +20

Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down Syndrome and Alzheimer’s disease brain is downregulated at the mRNA and dysregulated at the protein level

Gert Lübec, Masaru Nonaka, Kurt Krapfenbauer et al. · 1999 · 129 citations

Depletion of the high-abundance plasma proteins

M. Fountoulakis, Jean‐François Juranville, Lei Jiang et al. · Amino Acids · 2004 · 107 citations

High-abundance Plasma Proteins, Protein Function, Biochemistry +6

Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer’s disease and Down Syndrome

M. Fountoulakis, Nigel J. Cairns, Gert Lübec · 1999 · 101 citations